NCT01777555 - Efficacy and Safety Study of Inhaled CVT 301 in Parkinson's Disease Patients for Treatment of OFF Episodes | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 30, 2013

Primary Completion Date

January 31, 2014

Study Completion Date

January 31, 2014

Conditions

Idiopathic Parkinson's Disease

Interventions

DRUG

CVT-301

DRUG

Placebo

Trial Locations (22)

12401

Civitas Investigational Site 1011, Kingston

33427

Civitas Investigational Site 1004, Boca Raton

33601

Civitas Investigational Site 1015, Tampa

33948

Civitas Investigational Site 1002, Port Charlotte

44101

Civitas Investigational Site 1014, Cleveland

48025

Civitas Investigational Site 1001, Bingham Farms

48066

Civitas Investigational Site 1008, Roseville

48322

Civitas Investigational Site 1005, West Bloomfield

48880

Civitas Investigational Site 1009, Saint Louis

66101

Civitas Investigational Site 1007, Kansas City

72201

Civitas Investigational Site 1013, Little Rock

98033

Civitas Investigational Site 1003, Kirkland

02108

Civitas Investigational Site 1010, Boston

Unknown

Civitas Investigational Site 4003, Cassino

Civitas Investigational Site 4002, Chieti

Civitas Investigational Site 4001, Rome

Civitas Investigational Site 3001, Belgrade

Civitas Investigational Site 3002, Belgrade

Civitas Investigational Site 2004, Cambridge

Civitas Investigational Site 200, Glasgow

Civitas Investigational Site 2001, London

Civitas Investigational Site 2003, Stoke-on-Trent